Published in AIDS Weekly, July 25th, 2005
In a recently published study, investigators in South Africa conducted a study "to determine the quantitative and qualitative antibody responses to a pneumococcal conjugate vaccine (PnCV) in human immunodeficiency virus (HIV)-exposed infected and uninfected children. Children were randomized to receive either a PnCV or placebo at 6, 10 and 14 weeks of age.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.